ASPI Overview

ASP Isotopes Inc. is a development stage advanced materials company dedicated to the development of technology and processes to produce isotopes for use in multiple industries. Its proprietary technologies, the Aerodynamic Separation Process and Quantum Enrichment technology, are designed to enable the production of isotopes used in several industries. Its initial focus is on the production and commercialization of enriched Carbon-14 (C-14), Silicon-28 (Si-28) and Ytterbium-176 (Yb-176). It is also a provider of liquid helium with operations at the Virginia Gas Project in South Africa. Its nuclear fuels segment is focused on research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its specialist isotopes and related services segment is focused on research and development of technologies and methods used to separate isotopes for highly specialized target end markets.

Wall Street analysts forecast ASPI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ASPI is12.00 USD with a low forecast of 11.00 USD and a high forecast of 13.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

ASP Isotopes Inc revenue for the last quarter amounts to 16.66M USD, increased 1295.41

ASP Isotopes Inc. EPS for the last quarter amounts to -0.76 USD, increased 442.86

ASP Isotopes Inc (ASPI) has 271 emplpoyees as of April 26 2026.

Today ASPI has the market capitalization of 673.58M USD.